By Andrew Karpan ( August 6, 2021, 5:00 PM EDT) -- Pharmaceutical giant AstraZeneca is the latest to say the Patent Trial and Appeal Board's policy of rejecting patent reviews based on district court litigation violates the law, arguing in a new lawsuit that applying the policy to post grant reviews renders those procedures "meaningless."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.